Specifically, PPARγ ligand pioglitazone reduced tumor growth and metastasis in a mouse model as well as inhibiting the VEGF/fibroblast growth factor 2 (FGF2) production and angiogenesis promoted by chronic stress in murine breast cancer cells [98]. Here, VEGFA is linked to breast cancer.